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Abstract
Nanoparticles (NPs) synthesized using various chemical and physical methods are often
cytotoxic which restricts their use in biomedical applications. In contrast, metallic biogenic NPs
synthesized using biological systems such as plant extracts are said to be safer and their
production more cost effective. NPs synthesized from plants with known medicinal properties
can potentially have similar bioactivities as these plants. It has been shown that Salvia
africana-lutea (SAL) and Sutherlandia frutescens (SF) have antibacterial activities. This study
used water extracts of SAL and SF to produce biogenic silver NPs (AgNPs) and gold NPs
(AuNPs). The antibacterial activity of AgNPs and AuNPs was tested against two pathogens
(Staphylococcus epidermidis and P. aeruginosa). NP synthesis was optimized by varying the
synthesis conditions which include synthesis time and temperature, plant extract concentration,
silver nitrate (AgNO3) concentration and sodium tetrachloroaurate (III) dihydrate
(NaAuCl4 · 2H2O) concentration. The NPs were characterized using Ultraviolet-visible
(UV–vis) spectroscopy, dynamic light scattering, high-resolution transmission electron
microscopy (HR-TEM), and Fourier transform infrared (FT-IR) spectroscopy. SAL was able to
synthesize both Ag (SAL AgNP) and Au (SAL AuNP) nanoparticles, whilst SF synthesized Ag
(SF AgNP) nanoparticles only. The absorbance spectra revealed the characteristic surface
plasmon resonance peak between 400–500 nm and 500–600 nm for AgNP and AuNP,
respectively. HR-TEM displayed the presence of spherical and polygon shaped nanoparticles
with varying sizes whilst the Energy Dispersive x-ray spectra and selected area diffraction
pattern confirmed the successful synthesis of the AgNPs and AuNPs by displaying the
characteristic crystalline nature, optical adsorption peaks and lattice fringes. FT-IR spectroscopy
was employed to identify the functional groups involved in the NP synthesis. The microtitre
plate method was employed to determine the minimum inhibitory concentration (MIC) of the
NPs and the extracts. The water extracts and SAL AuNP did not have significant antibacterial
activity, while SAL AgNP and SF AgNP displayed high antibacterial activity. In conclusion, the
data generated suggests that SAL and SF could be used for the efficient synthesis of
antibacterial biogenic nanoparticles.
Keywords: antibacterial, gold nanoparticles, silver nanoparticles, Salvia africana-lutea,
Sutherlandia frutescens, synthesis
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1. Introduction
The scientific interest in the synthesis of colloidal/metallic
nanoparticles (NPs) using biological molecules has recently
gained momentum. This is due to the general perception that
biogenic nanoparticles are safer and environmentally friendly
in comparison to metallic nanoparticles synthesized using
physical and chemical methods, which have been reported to
be toxic, labour intensive and expensive. Additionally, the use
of harmful chemicals in the synthesis has been shown to limit
the biological use of the nanoparticles [1].
Of the currently utilised biological systems, plants are
most favoured as they are readily available and contain a
wide variety of phytochemicals that can potentially reduce
metal ions [2, 3]. Silver, gold, copper, platinum and titanium
metals are widely used for nanoparticle synthesis, with sil-
ver and gold being the most popular due to their unique bio-
logical and optical properties [3–5]. Numerous plants have
been used in the synthesis of AgNPs and AuNPs includ-
ingMedicago sativa, Azadirachta indica, Aspalathus hispida,
Asparagus ribicundus, and Dicerothamnus rhinocer [6–10].
Salvia africana-lutea (SAL) and Sutherlandia frutescens (SF)
are two indigenous South African plants with a long history
of use in traditional medicine. SAL has been used in the treat-
ment of skin and gastric disorders whilst SF is traditionally
known for its anticancer activities [11–13]. Rosmarinic and
carnosic acid, potent flavonoids associated with significant
anti-inflammatory, anti-microbial and anti-oxidant properties,
have been shown to be the most abundant chemical constitu-
ents of SAL extracts. It was also reported that the trimers and
tetramers of the plant possess antioxidant, anti-cancer and anti-
microbial activity [12, 14]. The documented high levels of the
non-protein amino acid compound L-canavanine in SF, a com-
pound associated with anti-cancer and antimicrobial activity
could explain the traditional use of the plant in cancer treat-
ment [15]. The complex interaction of different compounds
within the plant such as Pinitol, γ-aminobutyric acid, flavon-
oids, triterpene glycosides and other compounds has further
contributed significantly to the ethnopharmacological ability
of SF [16, 17]. There are thus several compounds present in
the extracts of these two plants that could be responsible for
the antibacterial activity reported for extracts of these plants.
AgNPs and AuNPs synthesised from these extracts could pos-
sibly also incorporate these compounds into the NPs.
Extracts of SAL and SF have been shown to have some
antimicrobial activity. The antibacterial activity of acetone,
ethanol and water extracts of SF was previously tested on
P. aeruginosa, S. aureus, E. coli and Enterococcus faecalis
[13]. The extracts were prepared from the leaves of the plant
and the study found that the MIC for these extracts including
the water extract was 10 mg ml−1. A study by Nielsen et al
tested the antimicrobial activity of methanol extracts of SAL
against several bacterial and fungal strains [18]. While the
reported MIC for E. coli, MRSA and Microsporum audouinii
was 39.06 µgml−1, theMIC for six other microorganisms was
above 100 µg ml−1. Kamatou and colleagues reported MIC
values of <1 mg ml−1 for SAL methanol: chloroform extracts
prepared from the aerial parts of the plants [19]. Since these
two plants have not been used previously to synthesize nano-
particles, this study investigated whether silver and gold nan-
oparticles can be produced from these extracts and whether
these nanoparticles have antibacterial activity.
The successful synthesis of NPs by bio-reduction and char-
acteristics of nanoparticles are affected by different factors
including the concentrations of the reactants, synthesis tem-
perature and time. It is therefore important to optimize these
parameters in the nanoparticle synthesis reaction. Addition-
ally, the differences in the chemical composition of medicinal
plants may also affect the properties and yield of the synthes-
ized nanoparticles, further justifying the need for the optim-
ization of the synthesis procedure. In this study we report on
the optimal conditions to synthesize AgNPs and AuNPs using
water extracts of SAL and SF. We show that while the water
extract have no significant antibacterial activity against the
bacterial strains we used, SAL AgNPs and SF AgNPs dis-
played high antibacterial activity.
2. Materials and methods
2.1. Chemicals and apparatus
Müeller-Hinton agar, Müeller-Hinton broth, sodium tetra-
chloroaurate (III) dihydrate (NaAuCl4 · 2H2O), silver nitrate
(AgNO3), yeast peptone broth (YPB) and Greiner bio-one
96 well flat bottom polystyrene microplates were acquired
from Sigma-Aldrich (St. Louis, USA). Bovine serum albu-
min (BSA) was purchased from Miles Laboratories (Pitt-
sburgh, PA, USA). Dulbecco’s phosphate buffered saline
(DPBS), Minimum Essential Medium Eagle-Alpha modi-
fication (MEM-α) and Roswell Park Memorial Institute
medium (RPMI) were acquired from Thermo-Fischer sci-
entific (Waltham, Massachusetts, USA).
2.2. Plant material
Fresh whole plants of SAL and SF were supplied by Harry
Goemans Garden centre (Kommetjie Road, Sunnydale, Cape
Town). The plants were grown from a reliable source of seed.
They were harvested during autumn and were not flowering
during harvest time.
2.3. Plant extraction
The leaves and stem of the plants were harvested, washed with
distilled water and air dried in the shade for 2 weeks. After dry-
ing, the plant material was finely ground and extracted. Water
extracts were prepared by adding 50 ml of boiling distilled
water to 5 g of plant material. The decoction was left stirring
for 24 h at 25 ◦C, after which it was filtered through glass
wool to entrap residual plant material. The extract was then
filtered using Whatman No.4 paper and further micro-filtered
using 0.45 µm filter, and subsequently freeze dried (VirTis
Genesis 25 ES Freeze drier, SP Scientific, Warminster, USA).
The dried extract was weighed and stored at 4 ◦C in the dark
for future use.
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2.4. Optimization of conditions for the synthesis and
screening of AgNPs and AuNPs
The optimization of synthesis was performed in Griener flat-
bottom 96-well plates using methods described by Elbagory
and colleagues for the synthesis of NPs [7]. The water extract
(40 µl) of SAL and SF was added at decreasing concentra-
tions (serial dilutions from 50 to 1.5625mgml−1) to eachwell.
To this 200 µl of AgNO3 or NaAuCl4 · 2H2O was added for
the synthesis of AgNPs and AuNPs, respectively, thus mak-
ing a reaction mixture ratio of 1:5 (Plant extract: AgNO3 or
NaAuCl4 · 2H2O). The AgNPs and AuNPs were synthesized
using 1 mM and 3 mM of AgNO3 and NaAuCl4 · 2H2O,
respectively at two temperatures, 25 and 70 ◦C. The AgNO3
and NaAuCl4 · 2H2O were all preheated at the specific syn-
thesis temperature prior to synthesis. The AgNPs were syn-
thesized in the dark to prevent the photoactivation of AgNO3.
The synthesis took place over a 24 h period and the ultraviolet-
visible (UV–vis) spectra of each sample was measured after
1, 3, 6 and 24 h using a POLARstar Omega spectrophoto-
meter (BMG labtech, Germany). The synthesis of AgNPs and
AuNPs was up-scaled to a final volume of 100 ml for fur-
ther characterization, stability assays and application using the
determined optimum synthesis conditions of plant extract con-
centration, AgNO3 or NaAuCl4 · 2H2O concentration, temper-
ature and time.
2.5. Characterization of synthesized AgNPs and AuNPs
The surface plasmon resonance (SPR) of the synthesized nan-
oparticles was measured by recording the UV–vis spectra ran-
ging from 300 nm to 700 nm. Following up-scaled synthesis,
the synthesized AgNPs and AuNPs were centrifuged at 13 000
rotations per minute (rpm) using the Eppendorf AG centrifuge
5417 R with a standard rotor (F-45-30-11) for 15 min and the
pellets werewashed three timeswith autoclaved distilledwater
as described previously [7]. This was performed to remove
any residual phytochemicals and AgNO3 or NaAuCl4 · 2H2O
not utilised in the nanoparticle synthesis reaction. After each
wash, the nanoparticles were re-suspended in volumes of
water that was equal to total reaction volume. This was done
to maintain the same nanoparticle concentration after wash-
ing the nanoparticles. In Eppendorf tubes, 1 ml of synthesized
nanoparticles were centrifuged at 13 000 rotations per minute
(rpm) for 15 min and the pellets air dried at 25 ◦C. The dried
pellets were weighed and the quantity of synthesized nano-
particles was determined as the mass of dried pellet in 1 ml of
synthesized nanoparticles. The hydrodynamic size, poly dis-
persity index (PDI) and zeta potential (ZP) of the synthesized
nanoparticles were determined using the dynamic light scat-
tering (DLS) technique. The analysis was performed using a
Zetasizer Nano ZS90 (Malvern Instruments Ltd, UK) with a
90◦ scattering angle at 25 oC. The washed nanoparticles were
diluted (1:10, v v−1) and placed into either the polystyrene
cuvette for hydrodynamic size and PDI determination or the
Disposable Capillary Cell (DTS1070) cuvettes for ZP ana-
lysis.
2.5.1. High-resolution transmission electron microscopy (HR-
TEM), energy dispersive x-ray spectra (EDX) and selected
area diffraction pattern (SAED) Synthesized, washed AgNPs
and AuNPs were prepared by placing a single drop of sample
solution onto a carbon-coated copper grid. These were allowed
to dry for 10 min under a Xenon lamp, after which the grids
were analysed under the transmission electron microscope
(Field Emission Transmission Electron Microscope, Tecnai
F20, FEI Company, Oregon USA) as described previously [7].
Themicroscope was operated at an acceleration voltage of 200
kV in a bright field mode. Concurrently, the Energy Dispers-
ive x-ray spectra (EDX) were collected using a lithium doped
silicon detector cooled using EDAX liquid nitrogen. Selected
area diffraction pattern (SAED) was also determined to char-
acterize the crystalline nature of the synthesized nanoparticles.
2.5.2. Fourier transform infrared (FT-IR) spectroscopy FT-
IR analysis was performed according to a previously repor-
ted method using the PerkinElmer spectrum one FT-IR spec-
trophotometer (Waltham, MA, USA) [20]. The purified dried
nanoparticles were mixed with potassium bromide (KBr) and
pressed into a pellet for analysis. Pressed pure KBr was used
for background correction.
2.6. Stability analysis of synthesized AgNPs and AuNPs
In a 96-well plate, the washed nanoparticles (100 µl) were
incubated with an volume of biological media as described
previously [21]. The in vitro stability of synthesized AgNPs
and AuNPs was tested by incubating the nanoparticles
with biological media (Minimum Essential MEM-α, MHB,
Roswell Park Memorial Institute medium, YPB), BSA, and
DPBS. The stability of the synthesizedAgNPs andAuNPswas
determined by observing the changes in the UV–vis spectra
(POLARstar Omega spectrophotometer, BMG labtech, Ger-
many) after 0, 1, 12 and 24 h incubation at 37 oC in the respect-
ive media or buffer.
2.7. Antibacterial testing
2.7.1. Bacterial strains Staphylococcus epidermidis (S. epi-
dermidis, ATCC 12 228) and P. aeruginosa (P. aeruginosa,
ATCC 27 853) was acquired fromAmerican Type Culture Col-
lection (ATCC, Manassas, VA, USA) and used as representat-
ive bacterial strains for the antibacterial testing.
2.7.2. Determining the minimum inhibitory concentration (MIC)
Microbial cultures were prepared by inoculating MHB
with single bacterial colonies and incubating the inoculum
overnight at 37 ◦C in a horizontal type-shaking incubator (LM-
530D, Taiwan). The bacterial suspensions were standardized
to 0.5 McFarland (∼1.5 x 108 cells ml−1) at spectrophotomet-
ric wavelength of 630 nm and further diluted to a final con-
centration of 5 × 105 cells ml−1. The diluted bacterial cul-
tures were treated with the water extracts and NPs. Treatments
with the water extracts were performed at concentrations ran-
ging between 50 and 0.39 mg ml−1, while the concentrations
3
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Figure 1. Illustration of synthesis of AgNPS and AuNPs from SAL, and SF. (A) represents biogenic nanoparticle synthesis using SAL
extract and (B)using SF extract.
of the NPs ranged from 1.5 to 0.012 mg ml−1. Ampicillin
was used as a positive control. Minimum Inhibitory Concen-
tration (MIC) was determined as described by Balouiri et al
[22]. The lowest concentration that inhibited visible bacterial
growth was recorded as the MIC. The experiment was done in
triplicate.
2.8. Statistical analysis
The data are expressed as mean ± standard deviation (SD).
Statistical differences between the means were considered sig-
nificant at p < 0.05 according to two-way ANOVA test fol-
lowed by a post hoc multiple comparison analysis (Turkey”s
test) using the GraphPadTM PRISM6 software package.
3. Results
3.1. Establishing the optimum conditions for the synthesis of
AgNPs and AuNPs
The synthesis of AgNPs and AuNPs from both SAL and SF
was optimized by varying reaction temperature, reaction time,
plant extract concentration and AgNO3 or NaAuCl4 · 2H2O
concentration. The first indication of successful biosynthesis
of nanoparticles was a uniform colour change as illustrated in
figure 1. AgNP synthesis produced a brown solution for both
SAL and SF. AuNP synthesis with SAL produced a red-violet
solution, while AuNP synthesis with SF produced a clear solu-
tion with visible particulates.
3.1.1. Determining the optimum concentration (OC) of react-
ants for the synthesis of AgNPs and AuNPs It has
been documented that both 1 mM and 3 mM of AgNO3
and NaAuCl4 · 2H2O are commonly used for AgNP and
AuNP synthesis, respectively [23–25]. These concentrations
of AgNO3 and NaAuCl4 · 2H2O were thus used in this study.
For SAL and SF plant extracts, the colour changes were more
rapid and homogenous when synthesis was performed with
3 mMAgNO3, while similar synthesis reactions could only be
observed with SAL plant extracts and 1 mMNaAuCl4 · 2H2O.
Hence, 1 mM NaAuCl4 · 2H2O was selected for the synthesis
of SAL AuNPs and 3 mM AgNO3 as the optimum concen-
tration for SAL AgNPs and SF AgNPs. With respect to plant
extract concentrations, the plant extract concentrations used
were 50, 25, 12.5, 6.25, 3.125 and 1.5625 mg ml−1. The reac-
tions weremonitored for colour changes at different time inter-
vals for 24 h. SF extracts were observed to produce a brown
solution at 6.25 and 3.125 mg ml−1 with AgNO3, while SAL
extracts produced a brown solutionwith AgNO3 and violet-red
with NaAuCl4 · 2H2O at concentrations of 3.125 mgml−1 and
1.5625 mg ml−1. The UV–vis spectrum was recorded at spe-
cific time points as shown in figure 2. The screen for AgNP
synthesis showed absorbance peaks for SAL and SF with
3 mM AgNO3, while the screen for AuNP synthesis showed
4






























































































































































































Figure 2. Effects of reaction time, plant extract concentration and AgNO3 or NaAuCl4 · 2H2O concentration on UV–vis spectra of
synthesised nanoparticles at 70 ◦C. (A) shows the UV–vis spectra for synthesis of AgNP and (B) shows the spectra for AuNP synthesis.
absorbance peaks for SAL with 1 mM NaAuCl4 · 2H2O, but
not SF. For both AgNPs and AuNPs, increased plant extract
concentration (12.5, 25 and 50 mg ml−1) resulted in increased
absorbance intensity. Hence 6.25 mg ml−1 of SF plant extract
was selected for SF AgNP synthesis and 3.125 mg ml−1 of
SAL plant extract was selected for the optimum synthesis of
SAL AgNP and SAL AuNP.
3.1.2. Determining the optimum reaction temperature for
AuNP and AgNP synthesis The AgNPs and AuNPs were
synthesized over a 24 h period at both 25 ◦C (data not
shown) and 70 ◦C (figure 2), however, no colour changes
were observed for all reactions at 25 ◦C. Furthermore, absence
of absorbance peaks on the UV–vis spectra, similar to those
observed at 70 ◦C for SF AuNPs shown in figure 2, was recor-
ded for all nanoparticle synthesis at 25 ◦C. Hence, 70 ◦C was
selected as the optimum temperature for SAL AgNP, SAL
AuNP and SF AgNP synthesis due to the presence of absorb-
ance peaks characteristic of AgNPs and AuNPs.
3.1.3. Determining the optimum reaction time for AuNP and
AgNP synthesis The UV–vis absorbance spectra were
measured after 1, 3, 6 and 24 h. As the synthesis progressed the
5
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Table 1. Summary of optimum conditions of AgNP and AuNP synthesis using SAL and SF plant extract.
















Salvia africana-lutea Silver SAL AgNP 3.125 3 70 24
Salvia africana-lutea Gold SAL AuNP 3.125 1 70 24
Sutherlandia frutes-
cens
Silver SF AgNP 6.25 3 70 24
Figure 3. Size distribution by number of synthesized SAL AgNP, SAL AuNP and SF AgNP.
intensity of the absorbance peaks increased. Absorbance max-
ima from 400 to 500 nm and 500 to 600 nm were observed for
SAL and SF AgNP (figure 2(A)) and SF AuNP (figure 2(B)),
respectively. Based on the UV–vis absorbance spectra data at
different temperatures, reaction times, plant extract concen-
tration and AgNO3 or NaAuCl4 · 2H2O concentrations the
optimum synthesis conditions were determined and are sum-
marised in table 1.
3.2. Characterization of the synthesized AgNPs and AuNPs
by dynamic light scattering
DLS is a technique commonly used in the determination of
particle size in colloidal suspensions [26]. The concentration
of the colloidal suspensions was 1 mg ml−1. DLS was used
to determine three important characteristics of the synthesized
AgNPs and AuNPs. These are hydrodynamic size (figure 3),
PDI and ZP, which can be used to predict the behaviour of
nanoparticles in biological media. The surface charge of col-
loidal nanoparticles was determined by measuring the ZP of
the nanoparticles (figure 4). Table 2 shows the charge, size and
distribution of the synthesized nanoparticles. All the synthes-
ized nanoparticles displayed a PDI greater than 0.2 and ZP less
than −30 mV.
3.3. Characterization of the synthesized AgNPs and AuNPs
using high-resolution transmission electron microscopy
(HR-TEM)
High-resolution transmission electron microscopy (HR-TEM)
was employed to analyse the morphology and size of the syn-
thesized nanoparticles. The synthesized Ag and Au nanostruc-
tures were polymorphic with varying sizes. This size vari-
ation was more pronounced with SAL AgNPs and SF AgNPs,
as seen in figure 5. Although the predominating shape was
spherical, SAL was also observed to produce polygon shaped
AgNPs and AuNPs.
Size distribution curves for the synthesized nanoparticles
measured from the HR-TEM images are indicated in figure 6.
The highest frequency of SAL AgNPs and SAL AuNPs were
6
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Figure 4. Zeta potential distribution curves of synthesized SAL AgNP, SAL AuNP and SF AgNP.
Table 2. Average hydrodynamic size, PDI and ZP of the AgNPs and AuNPs synthesized using the optimum conditions.
Nanoparticle Average hydrodynamic size ± SD (nm) Average PDI ± SD Average ZP ± SD (mV)
SAL AgNP 34.63 ± 4.53 0.63 ± 0.03 −41.1 ± 2.00
SAL AuNP 63.27 ± 8.94 0.51 ± 0.03 −34.7 ± 1.39
SF AgNP 261.2 ± 10.40 0.612 ± 0.02 −35.7 ± 1.53
ranging from 6–8 nm to 10–15 nm, respectively, whilst the
highest frequency of SF AgNPs was between 15 and 20 nm.
The nanoparticle diameter as determined by HR-TEM is sum-
marised in table 3.
Gold and silver elements were detected using EDX ana-
lysis in AuNP and AgNP, respectively as shown in fig-
ure 7. The position of strong optical adsorption peaks for
Au was observed at 2.3, 9.7 and 11.3 keV and for Ag
between 2.5 and 4 keV. The presence of nickel, cop-
per, carbon, argon, oxygen and chlorine peaks were also
found.
The crystalline nature of the synthesized AuNPs and
AgNPs was observed as the lattice fringes with specific spa-
cing, as illustrated in figure 8. The SALAgNPs and SF AgNPs
had a fringe spacing of 0.228 and 0.226 nm respectively, whilst
the SAL AuNPs had 0.233 nm fringe spacing. The SAED pat-
terns, which show the crystalline nature of the AgNPs and
AuNPs, are also displayed. After indexing, the rings for SAL
AuNPs were found to correspond with the (111), (200), (220)
and (311) face-centered cubic (fcc) of gold whilst those for
SAL AgNPs and SF AgNPs concur with (111), (200), (220),
(222) and (311) fcc of silver [7].
3.4. Characterization of the synthesized AuNPs and AgNPs
by Fourier transform infrared (FT-IR) spectroscopy
FT-IR measurements were done to identify the functional
groups of phytochemicals present in SAL and SF extracts
responsible for the reduction and/or stabilization of the syn-
thesized AuNPs and AgNPs. The Infrared (IR) spectrum of
SAL AgNPs displayed intense bands at 3414.29, 3241.07,
2920.96, 2049.04, 1625.92, 1237.48, 618.97 and 480.39 cm-
1, whereas intense bands for SAL AuNPs were observed at
3706, 3563.05, 3405.97, 3236.06, 2907.03, 2045.03, 1618.43,
1257.18, 855.96 and 620.75 cm-1. In the IR spectrum
of SF AgNPs, prominent absorption bands were located
at 3551.94, 3411.17, 3238.56, 2911.52, 2053.49, 1625.97,
1259.13, 1041.76, 620.31 and 481.75 cm-1 (figure 9). The bio-
synthesized nanoparticles and the corresponding plant extracts
used to synthesise the nanoparticles showed some similar
7
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Figure 5. High Resolution Transmission Electron Microscopy (HR-TEM) images of the nanoparticles.
Figure 6. Size distribution curves for synthesized AgNPs and AuNPs as determined by HR-TEM.
bands, whilst some of the bands of the nanoparticles appeared
shifted when compared to the FT-IR spectra of the extracts.
Similar bands were observed in all the synthesized nano-
particles. The band shifts are summarised in table 4.
8
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Table 3. Average particle diameter (PD) of synthesized
nanoparticles.
Nanoparticle Average PD ± SD (nm)
SAL AgNP 8.71 ± 5.13
SAL AuNP 17.84 ± 10.17
3.5. Stability of synthesized AgNPs and AuNPs in biological
media
The stability of synthesized nanoparticles in solvents is an
important parameter for their potential application. Stable nan-
oparticles are notably evenly distributed and do not agglom-
erate or aggregate when placed in a solvent. Changes in the
UV–vis spectra of nanoparticles over time in the presence of a
solvent can be used as an indication of nanoparticle stability.
In this study, the stability of the synthesized nanoparticles was
determined by evaluating changes in the UV–vis spectra over
a period of 24 h as shown in figure 10. The UV–vis changes
were observed after 0, 1, 12 and 24 h incubation of the synthes-
ized nanoparticles in MEM-α, RPMI, BSA, DPBS, YPB and
MHB. The synthesized nanoparticles and media were incub-
ated at 37 ◦C. This temperature was selected since most of
the intended biological applications of the nanoparticles was
going to be performed at 37 ◦C in these media. The synthes-
ized AgNPs and AuNPs were moderately stable, depicted by
the minimal changes in the UV–vis spectra.
3.6. Antibacterial effects of SAL and SF water extracts and
respective NPs
The MIC values for the water extracts were higher than
50 mg ml−1 as reported in table 5. SAL AgNPs, on the
other hand, exhibited high antibacterial activity against S. epi-
dermidis and P. aeruginosa with MIC values of 0.1875 and
0.375 mg ml−1 respectively. The growth of both bacterial
strains were not affected by SAL AuNPs at the concentrations
used in this study.
4. Discussion
4.1. Synthesis of AgNPs and AuNPs
The biosynthesis of NPs using plants involves the reduc-
tion of metallic ions by phytochemicals that are present in
the plant extract. The reduction of the metallic ions is fol-
lowed by nucleation and subsequent NP formation and may
end with the capping of the NP with capping agents that sta-
bilize the synthesised NPs [23]. The successful synthesis of
AgNPs and AuNPs was indicated by the appearance of colour
change after AgNO3 or NaAuCl4 · 2H2O was incubated with
the optimum concentration of the plant extract. The synthes-
ized AgNP solution exhibited the characteristic brown colour
whilst the AuNP solution appeared red-violet (figure 1). The
synthesis of AuNPs using SF, failed to produce a uniform col-
our change and suggest that SF might require synthesis con-
ditions other than the conditions e investigated in this study.
The uniform colour change is a result of SPR of the synthes-
ized nanoparticles [6]. The UV–vis spectra confirmed the syn-
thesis of nanoparticles by displaying peaks characteristic of
solutions of AgNPs and AuNPs. The intensity of the absorb-
ance peak (λ-max) is reflective of the size and concentration
of synthesized nanoparticles [27]. The SPR produced λ-max
between 400 and 500 nm for AgNPs, and between 500 and
600 nm for AuNPs. These optical characteristics are a result of
the excitation of the longitudinal plasmon vibration [28, 29].
The absence of a homogenous colour change and character-
istic absorbance peak has been associated with the failure of
nanoparticle synthesis [30], as observed when SF was reacted
with NaAuCl4 · 2H2O. The λ-max of SAL AgNP and SAL
AuNP were around 472 and 532 nm, respectively, whereas for
SF AgNP was around 432 nm, confirming nanoparticle syn-
thesis.
4.2. Optimization of different synthesis parameters
The analysis of the morphology and size of synthesized nan-
oparticles is of great importance because the variation in size
and shape of biogenic nanoparticles may affect their biomed-
ical application. This variation is due to the uniqueness of
the phytochemical blueprint of the plants. Additionally, sev-
eral parameters of synthesis, which include reaction time,
temperature and concentrations of the reactants, may affect
the quality and quantity of the nanoparticles [7]. Numer-
ous studies have used varying concentrations of AgNO3 and
NaAuCl4 · 2H2O in nanoparticle synthesis [7, 31–33]. How-
ever, 3 mM AgNO3 and 1 mM of NaAuCl4 · 2H2O have con-
sistently shown to be suitable concentrations for biogenic nan-
oparticle synthesis. This was corroborated by the observations
of this study, which reported a more defined colour change
when SAL AgNP, SAL AuNP and SF AgNP were synthes-
ized.
Different concentrations of SAL and SF extracts (50, 25,
12.5, 6.25, 3.125 and 1.5625 mg ml−1) were reacted with
AgNO3 and NaAuCl4 · 2H2O (3 mM and 1 mM) to produce
Ag and Au nanoparticles, respectively. All the higher extract
concentrations assessed (50, 25 and 12.5 mg ml−1) showed
colour change suggesting successful nanoparticle synthesis.
In contrast, no colour changes were observed for SF extracts
reacted with NaAuCl4 · 2H2O suggesting that AuNP was not
produced. However, the absorbance peaks produced at higher
plant concentrations were noisy which may suggest that high
plant extract concentrations contain concentrated phytochem-
ical content utilised in the synthesis. Furthermore, at lower
plant extract concentrations, 6.25 mg ml−1 for SF extract with
AgNO3, and 3.125 mg ml−1 for SAL extract with AgNO3 and
NaAuCl4 · 2H2O displayed more defined absorbance peaks.
Broader peaks were observed when 1.5625 mg ml−1 SAL
extract was used to synthesise SAL AgNP and SAL AuNP,
and 3.125 mg ml−1 SF extract in the synthesis of SF AgNP.
Broader peaks result from the insufficiency of biomolecules
required for capping and stabilization of the synthesized nan-
oparticles [30]. The variations in the values of absorbance sig-
nify changes in the nanoparticle size and concentration [34].
Sharper absorbance peaks observed for SAL AgNP and SAL
9
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Figure 7. Energy Dispersive x-ray Spectroscopy (EDX) spectra of SAL AgNPs, SAL AuNPs and SF AgNPs. The red arrows show Ag and
green arrows Au peaks.
AuNP corresponded with the generally smaller sized nano-
particles, while broader absorbance peaks were observed for
larger sized SF AgNP. This observation was in agreement with
observations reported by Ibrahim (2015) [35].
The reaction time was optimized by monitoring the reac-
tion over a 24 h period. Interestingly, for all nanoparticles the
intensity of the λ-max absorbance peaks increased with time,
indicating an increase in the quantity of nanoparticles pro-
duced over time. Elbagory and colleagues reported on the cor-
relation of the absorbance and number of nanoparticles in solu-
tion [7]. As the reaction temperature was increased, the syn-
thesis rate of both AgNPs and AuNPs also increased. Hence,
the synthesis temperature of 70 ◦C allowed for the successful
synthesis of SAL AgNP, SAL AuNP and SF AgNP. Increase
in synthesis temperature was previously shown to increase
both the synthesis rate and final conversion of metallic ions
to nanoparticles [27, 36].
4.3. Characterization of synthesized nanoparticles
4.3.1. The characterization of synthesized nanoparticles by
hydrodynamic size, zeta potential and PDI. The average
hydrodynamic size, ZP and PDI of the synthesized nano-
particles were determined using DLS and is reported in table
2. Hydrodynamic size is depended on the interaction of nan-
oparticles with the solvent the nanoparticles are suspended
in. The average hydrodynamic size was 34.63, 63.27 and
261.20 nm for SAL AgNP, SAL AuNP and SF AgNP, respect-
ively. All synthesized nanoparticles had an average ZP less
than−30 mV (table 2). It is been suggested that nanoparticles
with such high negative ZP values are stable [37]. This stabil-
ity is a result of the strong repulsion forces existing between
the negatively charged nanoparticles, preventing their aggreg-
ation. The PDI measures the distribution of nanoparticles in
colloid suspension and is measured as a value between 0 and
1. A PDI value between 0.1 and 0.2 suggests that nanoparticles
are monodispersed, i.e. the nanoparticles have a similar size
and shape [38]. Considering the synthesized nanoparticles had
PDI values greater than 0.2, the nanoparticles can be classified
as polydispersed, i.e. of different size and shape.
4.3.2. High-resolution transmission electron microscopy (HR-
TEM) As seen in figure 5, the HR-TEM revealed the pres-
ence of nanoparticles with different sizes and shapes. This cor-
roborated the conclusion made from the PDI values reported
in table 1. The hydrodynamic size of the synthesized nano-
particles was 34.63, 63.27 and 261.20 nm, whilst the HR-TEM
core size was 8.71, 17.84 and 21 nm for SAL AgNP, SAL
AuNP and SF AgNP, respectively. Such apparent discrepan-
cies between size determination done by HR-TEM and DLS
has been reported previously [7]. The hydrodynamic size is
typically larger than the HR-TEM derived size as it is influ-
enced by the interaction of the nanoparticle surface with the
solvent [21]. Based on these results, our observations con-
curred with previously reported studies. The geometrical and
size variation has been widely reported for biogenic nano-
particles and has been associated with the phytochemical pro-
file of the selected plants [7, 39–41]. The common phytochem-
ical groups responsible for the reduction of Ag and Au ions in
10
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Figure 8. HR-TEM images and SAED analysis of the nanoparticles. (A), (C) and E show HR-TEM and lattice fringes. The inserts on (A),
(C) and (E) shows the measurement of the lattice fringes for the respective nanoparticle. (B), (D) and (F) show the SAED.
the synthesis of nanoparticles have been identified as flavon-
oids, alkaloids, flavones, amino acids, steroids, polyphenols
and proteins [29].
The elemental profile of the nanoparticles is shown on the
EDX spectra (figure 7). The presence of strong optical adsorp-
tion peaks corresponding to Ag (2.5–4 keV) on the spectra for
SAL AgNP and SF AgNP, and Au (2.3, 9.7 and 11.3 keV)
for SAL AuNP further confirms the successful synthesis of
the Ag and Au nanoparticles. Additionally, adsorption peaks
corresponding to nickel, copper, carbon, argon, oxygen and
chlorine elements were also observed. These elements could
originate from the grid utilised during HR-TEM as well as
plant extracts involved in the nanoparticle synthesis. The lat-
tice fringes present on the synthesized nanoparticles confirm
the crystalline nature of the nanoparticles (figure 8). This was
further confirmed by the observed SAED pattern. The lat-
tice fringe spacing was similar to that previously reported for
AgNPs or AuNPs synthesized from Murraya koenigii [30],
Iresine herbstii [39], Pulicaria glutinosa [20] and Medicago
sativa [8]. Ring positioning for the synthesized AuNPs (111,
200, 220, 311 and 222 fcc) and AgNPs (111, 200, 220 and 311
fcc) on the SAED concurs with numerous published studies [7,
40–42].
4.3.3. Fourier transform infrared (FT-IR) spectroscopy FT-
IR spectroscopy was performed on the extracts and nano-
particles to identify functional groups that are similar between
the extract and the nanoparticles. The Infrared (IR) spectro-
scopy observes the vibrations of molecular bonds and hence
provides information on the nature of the bonds and func-
tional groups in the molecules. The generated information
can be utilised to identify functional groups from phytochem-
icals that are involved in the bioreduction of AgNO3 and
NaAuCl4 · 2H2O and thus confirm the involvement of the
phytochemicals in the synthesis of the nanoparticles. Numer-
ous studies suggest that different phytochemicals may play a
role in the synthesis of biogenic AgNP and AuNP [21, 29,
30]. Figure 9 shows the presence of several functional groups
that are present in both the extract and nanoparticles. The
11
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Figure 9. FT-IR spectra of plant extracts and the respective nanoparticles synthesized from the extracts. (A)shows the FT-IR spectra of SAL
and SAL AgNP, (B) shows the FT-IR spectra of SAL and SAL AuNP and (C) shows the FT-IR of SF and SF AgNP.
spectra of some functional groups appear to be shifted in the
nanoparticle samples. The shifts are summarised in table 4
and suggest the involvement of the corresponding functional
groups in the synthesis of the nanoparticles. Interestingly, sim-
ilar peaks were observed in the FT-IR spectra of synthesized
nanoparticles from both plants, suggesting similar functional
groups and therefore similar phytochemicals may be involved
in the synthesis of the nanoparticles. For instance visible bands
at 2920.96, 2907.03 and 2911.52 cm-1 may be a result of
the C-H stretch alkanes whilst the defined bands at 3414.29,
3405.97 and 3411.17 cm-1 for SALAgNP, SALAuNP and SF
AgNP respectively, probably correspond with the O-H group
(figure 9). Additionally, SAL AgNPs and SAL AuNPs also
displayed respective visible bands at 1237.48 and 1257.18 cm-
1 suggesting the stretching vibration of the C-O functional
group. The weak but notable band at 1041.76 cm-1 for the
SF AgNPs could be assigned as absorption bands for—C-O-
C- whilst the 3238,56 cm-1 band may correspond to the N-
H functional group. The bands corresponding to the C–O and
O–H bonds on the FT-IR spectra indicate the possible involve-
ment of phenolic acids, carbohydrates, flavonoids and terpen-
oids in the capping and stabilization of the synthesized nan-
oparticles [30, 40, 41]. The HPLC phytochemical profile of
SAL has revealed that the plants’ are high in flavonoid content
especially rosmarinic and carnosic acid [12]. The involvement
of compounds that contain hydroxyl and carbonyl groups in
nanoparticle synthesis has been reported in numerous stud-
ies [30, 41, 42]. A study by Aboyade and colleagues reported
that SF contained significant levels of free and protein-bound
amino acids [17]. Balashanmugam and colleagues suggested
that amino acids and proteins may act as stabilizers of nano-
particles after the bioreduction process [43]. The shifted band
12
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Table 4. Comparison of FT-IR spectra of SAL and SF aqueous extracts and their respective nanoparticles.
FT-IR peaks of aqueous
extracts (cm−1)
FT-IR peaks
of NPs (cm−1) Shift valuea(cm−1)
Possible func-
tional groups References
3384.65 3414.29 −29.64 O-H (Alcohols) 9, 20, 40
2927.83 2920.96 6.87 C-H (Alkanes) 9, 20, 32, 40, 41
1609.34 1625.92 −16.58 C = C (Aromatics) 9, 30, 41
SAL AgNP




3384.65 3405.97 21.32 O-H (Alcohols) 9, 20, 40
2927.83 2907.03 20.8 C-H (Alkanes) 9, 20, 32, 40, 41
1609.34 1618.43 −9.09 C = C (Aromatics) 9, 30, 41
SAL AuNP




3254.44 3238.56 15.88 N-H (Amine) 32
2937.2 2911.52 25.68 C-H (Alkanes) 9, 20, 40
SF AgNP
1050.32 1041.76 8.56 C-O-C 30, 40, 41
aThe shift values were calculated by subtracting the transmittance peak of synthesized NPs from the transmittance peak of the aqueous extracts.
Figure 10. Stability of synthesised nanoparticles during incubation in biological media and buffers at 37 ◦C. UV–vis analysis of the AuNP
and AgNP was perform over a 24 h period. Arrows show the peaks due to the phenol red content in the respective media. Abbreviations:
BSA: Bovine Serum Albumin; DPBS: Dulbecco’s Phosphate Buffered Saline; MEM-α: Minimum Essential Medium Eagle-Alpha
Modification; MHB: Müeller Hinton Broth; RPMI: Roswell Park Memorial Institute medium.
at 3238.56 cm-1 in the FT-IR spectrum of SF AgNP, is attrib-
uted to the N-H group of amines, affirming the above sugges-
tion. The benign nature of the identified capping and stabiliz-
ing agents may allow the use of the synthesized nanoparticles
in the food, medicinal and cosmetic industries. However, fur-
ther analysis of these synthesized nanoparticles is required for
the precise identification of the actual molecules responsible
for the synthesis of nanoparticles.
4.3.4. Stability of nanoparticles in biological media Any
biomedical application of the nanoparticles would first require
in vitro and in vivo testing. It is therefore important to
confirm the stability of these nanoparticles in biological envir-
onments. Biologically stable nanoparticles do not aggregate
when placed in biological media over an extended period of
time [21]. The stability of the synthesized nanoparticles using
SAL and SF extracts is reported in figure 10. Uv–vis analysis
was used to determine changes in the stability of the nano-
particles. The stability of the nanoparticles was evaluated at
37 ◦C since most in vitro and in vivo applications are per-
formed at this temperature. When the SAL AgNP and SF
AgNP were placed to MHB, the absorption peaks changed
only moderately, implying that the nanoparticles are stable in
the respective media. However the absorption peaks of SAL
AuNP flattened with time in both MHB and YPB, showing the
13
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Table 5. The MIC values of SAL and SF extracts and synthesized
nanoparticles against selected microorganisms.
Bacterial strains
Test samples (mg ml−1) S. epidermidis P. aeruginosa
SAL extract >50 >50
SAL AgNP 0.1875**∗ 0.375**∗
SAL AuNP − −
SF extract >50 >50
SF AgNP 0.75**∗ 0.75**∗
Ampicillin 0.001 2
**∗Statistical significance (p<0.001) compared to the activity of
synthesizing water extract. – means no activity observed with highest
concentration of 1.5 mg ml−1. MIC < 1 mg ml−1 are in bold.
unstable nature of the nanoparticles in the biological media.
Even though the absorption spectra of the synthesized nano-
particles in the other biological media (MEM-α, RPMI, BSA,
DPBS and YPB) broadened slightly over time, the resulting
λ-max corresponding to the SPR of AgNP and AuNP did
not change meaning synthesized SAL AgNP, SAL AuNP and
SF AgNP were still present in solution. The broadening and
slight flattening might be as a result of some of the synthes-
ized nanoparticles disintegrating or agglomerating within the
selected media [6]. Agglomeration has been reported to res-
ult in changes in the surface morphology of the synthesized
nanoparticles [44]. A second red–shifted peak was observed
for SF AgNPs in MEM-α and RPMI and shown by the red
arrows in figure 8. This observation could be associated with
the phenol content of the media. However, additional assays
will be required for the confirmation of this assumption.
4.4. Antibacterial activity of SAL, SF and synthesized
nanoparticles
This study found that water extracts of SAL and SF did not
display any significant antibacterial activity against S. epider-
midis and P. aeruginosa. This is in agreement with a previous
study, which reported that water extracts of SF have only weak
antimicrobial activity [13]. A natural agent is considered a
noteworthy antimicrobial agent if it is MIC value is 1 mgml−1
and below [45]. This study shows that both SALAgNP and SF
AgNP haveMIC values below 1mgml−1, which demonstrates
that these NPs have significant antimicrobial properties. How-
ever, SAL AuNP did not have any antimicrobial properties,
which suggest that the silver ions played a role in the anti-
bacterial activity. A previous study investigated the antibac-
terial activity of colloidal AgNP that was produced by elec-
trolysis and reported MIC values of 4 and 2 mg ml−1 for S.
epidermidis and P. aeruginosa, respectively [46]. The anti-
bacterial activity of both SAL AgNPs and SF AgNPs is thus
significantly higher than colloidal AgNPs produced by elec-
trolysis. It is likely that bioactive phytochemicals present in
the plant extract were incorporated into the AgNPs, resulting
in the production of biogenic AgNPs that have high antibac-
terial activity. However, further analysis which can identify
the phytochemicals involved in the synthesis of SAL AgNPs
and SF AgNPs is required. Other studies which describe the
synthesis of biogenic AgNPs from plant extracts also reported
the enhanced bioactivity of biogenic AgNPs when compared
to the antibacterial activity of the plant extracts [6, 9, 47]. The
difference in the antibacterial activity of SAL AgNPs and SF
AgNPs could also result from the differences in the phyto-
chemical composition of SAL and SF.
5. Conclusion
Since all plant species have a specific phytochemical blue-
print, their potential to reduce metallic ions and produce nan-
oparticles is expected to be different. Additionally, the nano-
particles synthesized from different plants tend to display dif-
ferent characteristics as illustrated by our findings. SAL and
SF water extracts were used to successfully produce Ag nano-
particles (SALAgNPs and SF AgNPs, respectively). The SAL
extract also produced Au nanoparticles (SAL AuNPs). The
optimal plant extract concentrations to synthesize 1 mg ml−1
of SAL AgNPs, SF AgNPs and SAL AuNPs was 3.125,
6.25 and 3.125 mg ml−1 respectively. The optimal AgNO3
and NaAuCl4 · 2H2O concentrations were 3 mM and 1 mM
respectively. The optimal synthesis temperature was at 70 ◦C.
HR-TEM confirmed the presence of spherical and polygon
shaped biogenic nanoparticles of varying sizes. SAL AgNP
and SF AgNP demonstrated significant antibacterial activity
against S. epidermidis and P. aeruginosa. These two microor-
ganisms are common causes of nosocomial infections. This
suggest that these NPs may be useful agents to combat this
form of infection.
These agents can eventually be incorporated into differ-
ent products such as bandages and topical ointments for the
treatment of open wounds prone to infections. It is therefore
recommended that further investigations for clinical applica-
tions such as drug delivery and anticancer activities of these
agents be assessed.
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